May 6th 2024
Analysis reveals rising hospitalization rates among pregnant women with hepatitis C virus (HCV) and age as a critical factor influencing maternal and fetal health outcomes.
HCV Reinfection Rare Among Patients Receiving Opioid Agonist Therapy
August 24th 2022Rates of hepatitis C reinfection were low among people receiving opioid agonist therapy, according to a new study, which highlights the importance of risk reduction interventions and HCV treatment for people who inject drugs and people receiving opioid agonist therapy.
Read More
Hepatitis B Infections Drop in Asia Pacific Region, but Deaths from HBV and HCV Rise
December 21st 2021Incidence of hepatitis B has fallen in the Asia and Pacific region, but progress against hepatitis C in the region has lagged and morbidity and mortality continued to rise, underscoring a need to improve diagnosis and linkage of care, according to a recent report.
Read More
ACIP Updates Recommended Vaccines and Immunization Schedules after 2-Day Meeting
November 3rd 2021The CDC’s Advisory Committee on Immunization Practices voted to recommend hepatitis B, orthopoxviruses, and Ebola vaccines to certain populations, as well as approving 2022 immunization schedules for children, adolescents, and adults.
Read More
Simplifying Access to Hepatitis C Virus Care Is Effective in Resource-Constrained Settings
April 2nd 2021Simplifying access to hepatitis C virus care, including decentralized community-based care and task shifting to non-specialists, could improve testing and treatment for patients in settings with limited resources.
Read More